Is HQY a Buy or a Sell? The Bull and Bear Case (2026)

That depends on which case you find more convincing, and both are on this page. The bull case rests on The cash repricing ladder, with revenue (ttm) at ~$1.34B. The bear case rests on custodial revenue is the profit engine and it depends on rates HealthEquity does not control, so a sustained decline in market yields would eventually reset renewing contracts lower, just as slowly as the current tailwind arrived. Analysts covering it are spread from $105.00 to $135.00, which is itself a signal that this is genuinely contested. If you believe the thesis, the real questions become sizing and overlap rather than timing. Walnut is not an investment adviser and this is not a recommendation.

Nobody can answer that for you, and the honest version of the question is narrower: has anything changed in the reason you bought it? The bear case on this page is the place to check. Custodial revenue is the profit engine and it depends on rates HealthEquity does not control, so a sustained decline in market yields would eventually reset renewing contracts lower, just as slowly as the current tailwind arrived. If that risk is what you were worried about and it is now playing out, that is a real signal. If the price simply fell while the thesis held, that is a different situation entirely. The most pessimistic published target is $105.00, +2.2% from the $102.79 price, which is one analyst's downside case rather than a floor. Walnut is not an investment adviser.

The cash repricing ladder. HealthEquity locks member cash into multi-year contracts with insurance companies and banks, so its yield moves in slow motion rather than with the Fed. The most optimistic analyst target on HQY is $135.00, +31.3% from the $102.79 price. That figure is only reachable if this thesis works close to its best case.

Custodial revenue is the profit engine and it depends on rates HealthEquity does not control, so a sustained decline in market yields would eventually reset renewing contracts lower, just as slowly as the current tailwind arrived. Service revenue grew only 3% last quarter and average service fees per account are falling, which means growth in accounts is not translating cleanly into growth in fees. Competition for the employer default slot is intense, with Optum Bank, Fidelity and HSA Bank all able to undercut on price, and Fidelity in particular markets a no-fee individual HSA. A fiscal 2025 cybersecurity incident involving a business partner's compromised user account left the company facing a consolidated putative consumer class action in federal court in the District of Utah, where it filed a renewed motion to compel arbitration on May 15, 2026, plus several regulatory inquiries; separately, several plaintiff firms have publicized securities investigations following the March 2025 guidance reaction, though the latest 10-Q discloses no pending securities fraud case. Complementary benefit accounts (FSA, HRA, COBRA, commuter) were flat at 7.2 million, so the non-HSA half of the account base is not currently contributing growth. The most pessimistic published target is $105.00, +2.2% from the current price, which is roughly what the stock is worth if these risks bite rather than the drivers.

HealthEquity is the largest independent non-bank custodian of health savings accounts in the United States, and also administers consumer-directed benefits for employers.

Decide that in advance, because it is far harder to think clearly once a position is moving against you. The concrete tripwires here: the driver behind the bull case (The cash repricing ladder) stalling in the reported numbers rather than in the narrative, the risk above (custodial revenue is the profit engine and it depends on rates HealthEquity does not control, so a sustained decline in market yields would eventually reset renewing contracts lower, just as slowly as the current tailwind arrived) turning from a possibility into a reported fact, or the position growing large enough that a bad outcome would matter to your whole portfolio regardless of who is right.

It is the custodian and administrator behind health savings accounts and related workplace benefit accounts. HealthEquity holds the money, runs the account and the payment card, handles claims substantiation for FSAs and HRAs, and administers COBRA and commuter benefits. As of April 30, 2026 it looked after 10.6 million HSAs and 7.2 million other accounts, 17.8 million in total, for employers across the United States.

Three ways. Service revenue is per-account administration fees paid by employers, health plans and members, plus fees on invested balances and its marketplace. Custodial revenue is the spread it keeps on member cash placed with insurance-company partners and banks. Interchange revenue comes from merchants each time a member swipes a benefits card. In the April 2026 quarter those lines were $122.9 million, $174.3 million and $57.4 million.

HealthEquity, Inc., a Delaware corporation headquartered at 15 West Scenic Pointe Drive in Draper, Utah. Its shares trade on the Nasdaq Global Select Market under the ticker HQY, and it files with the SEC under CIK 1428336 and commission file number 001-36568. Its fiscal year ends on January 31, so fiscal 2027 covers February 2026 through January 2027.